Reported 1,026,443 shares, up 142,205 (16.1%) from the prior quarter.
Reported value 20.6%; share count 16.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-12-31 | 684174 |
| 2024-03-31 | 2715878 |
| 2024-06-30 | 33879713 |
| 2024-09-30 | 45434965 |
| 2024-12-31 | 59155689 |
| 2025-03-31 | 27911667 |
| 2025-06-30 | 29354811 |
| 2025-09-30 | 48076724 |
| 2025-12-31 | 260024049 |
| 2026-03-31 | 284892641 |
| 2026-06-30 | 343656004 |
| 2026-09-30 | 304148963 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 1,044,423 | +17,980 (1.8%) | < 0.01% | $304,148,963 | 2026-11-12 | |
| Q2 2026 | Added | 1,026,443 | +142,205 (16.1%) | 0.01% | $343,656,004 | 2026-08-07 | |
| Q1 2026 | Added | 884,238 | +2,023 (0.2%) | < 0.01% | $284,892,641 | 2026-05-15 | |
| Q4 2025 | Reduced | 882,215 | -24,893 (-2.7%) | < 0.01% | $260,024,049 | 2026-02-13 | |
| Q3 2025 | Added | 907,108 | +209,015 (29.9%) | < 0.01% | $48,076,724 | 2025-11-14 | |
| Q2 2025 | Reduced | 698,093 | -38,946 (-5.3%) | < 0.01% | $29,354,811 | 2025-08-14 | |
| Q1 2025 | Reduced | 737,039 | -31,616 (-4.1%) | < 0.01% | $27,911,667 | 2025-05-15 | |
| Q4 2024 | Reduced | 768,655 | -20,969 (-2.7%) | < 0.01% | $59,155,689 | 2025-02-14 | |
| Q3 2024 | Reduced | 789,624 | -29,518 (-3.6%) | < 0.01% | $45,434,965 | 2024-11-14 | |
| Q2 2024 | Added | 819,142 | +774,634 (1740.4%) | < 0.01% | $33,879,713 | 2024-08-14 | |
| Q1 2024 | Added | 44,508 | +13,800 (44.9%) | < 0.01% | $2,715,878 | 2024-05-15 | |
| Q4 2023 | New | 30,708 | +30,708 (0.0%) | < 0.01% | $684,174 | 2024-02-14 |
Who else reported the position
352 managers reported PRAXIS PRECISION MEDICINES I for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Jupiter Topco LLC | New | 3,421,374 | +3,421,374 | 0.47% | $1,145,994,051 | 1 qtr |
| FMR LLC | Added | 2,316,907 | +155,964 | 0.03% | $775,677,279 | 11 qtrs |
| BlackRock Inc | Reduced | 2,292,585 | -32,344 | 0.01% | $767,534,532 | 8 qtrs |
| PERCEPTIVE ADVISORS LLC | Unchanged | 2,035,986 | 0 | 10.23% | $681,627,753 | 10 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 1,753,198 | 0 | 2.94% | $586,953,158 | 10 qtrs |
| Orbis Allan Gray Ltd | Reduced | 1,529,788 | -942,692 | 1.76% | $512,157,724 | 3 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 1,335,185 | +578,437 | 0.02% | $447,006,586 | 2 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 1,235,299 | +13,355 | < 0.01% | $413,565,752 | 2 qtrs |
| STATE STREET CORPORATION This report | Added | 1,026,443 | +142,205 | 0.01% | $343,656,004 | 11 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Added | 1,015,480 | +199,741 | 0.48% | $339,972,549 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 07, 2026
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 147,865
- Shared
- 200
- None
- 878,378
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.